EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception

Leonardo Jacobsen iD, Diogo Pinto da Costa Viana iD, Graciela Morgado Folador, Eduardo Schor, Adriana Luckow Invitti iD

International Journal of Molecular Sciences · 24.06.2026 · 27 (13) · 5678

DOI: 10.3390/ijms27135678 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.06.2026. Verfasst von Leonardo Jacobsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Brazilian Society for Research and Teaching in Medicine (SOBRAPEM), São Paulo 01318-901, Brazil. Hauptthemen laut MEDLINE: Endometriosis, Tirzepatide, Incretins, Nociception. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is increasingly recognized as a chronic systemic disorder extending beyond the classical estrogen-dependent paradigm, integrating metabolic, immune, fibrotic, and nociceptive pathways that sustain lesion persistence and refractory pelvic pain. We propose a mechanistic, translational hypothesis in which tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, may modulate four interconnected pathological axes of refractory endometriosis—Warburg-type metabolic reprogramming with lactate accumulation, peritoneal immune dysfunction, NF-κB/NLRP3/TGF-β1-driven inflammatory–fibrotic remodeling, and persistent nociceptive sensitization—through three convergent molecular nodes: AMPK-associated signaling, GLP-1 receptor activity in peritoneal macrophages and spinal microglia, and the NF-κB/NLRP3/TGF-β1 axis. Particular emphasis is placed on the concept of “peritoneal incretin deficiency”, characterized by reduced peritoneal GLP-1 concentrations and increased expression of incretin-degrading proteases. This concept currently rests on a single, non-replicated case–control study, and the broader mechanistic chain is supported largely by indirect evidence extrapolated from adjacent inflammatory, metabolic, and neuroimmune disease models rather than by endometriosis-specific data. Direct experimental or clinical validation in endometriosis-specific models is currently absent. Accordingly, this article represents a hypothesis-generating framework rather than evidence of established efficacy, or a clinical treatment recommendation, intended to guide future mechanistic and prospective clinical investigation of incretin-based modulation as a potential adjunctive strategy in refractory endometriosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisTirzepatideIncretinsNociceptionPeritoneumFemaleHumansAnimalsFibrosisSignal Transduction

Stichwörter der Autor:innen

AMPKGLP-1 receptor agonistsNLRP3 inflammasomeTGF-β1chronic pelvic painendometriosisimmunometabolismmetabolic reprogrammingperitoneal incretin deficiencytirzepatide

Substanzen

TirzepatideIncretins

Autor:innen und Institutionen

  • Brazilian Society for Research and Teaching in Medicine (SOBRAPEM), São Paulo 01318-901, Brazil.
  • Department of Gynecology, Escola Paulista de Medicina, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04024-002, Brazil.
  • Brazilian Society of Personalized Medicine (SBMP), São Paulo 04552-050, Brazil.

ORCID-Profile: Leonardo Jacobsen, Diogo Pinto da Costa Viana, Adriana Luckow Invitti

Zitieren

APA

Jacobsen, L., Viana, D. P. D. C., Folador, G. M., Schor, E., & Invitti, A. L. (2026). Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception. International Journal of Molecular Sciences, 27(13), 5678. https://doi.org/10.3390/ijms27135678

Vancouver

Jacobsen L, Viana DPDC, Folador GM, Schor E, Invitti AL. Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception. International Journal of Molecular Sciences. 2026;27(13):5678. doi:10.3390/ijms27135678

BibTeX
@article{Jacobsen2026,
  author = {Jacobsen, Leonardo and Viana, Diogo Pinto da Costa and Folador, Graciela Morgado and Schor, Eduardo and Invitti, Adriana Luckow},
  title = {Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {5678},
  doi = {10.3390/ijms27135678}
}
Kostenlos starten →